Product Program year 2020 Source: CMS Open Payments

Mulpleta

Drug Hepatology (Liver, Pancreatic, Gall Bladder)

NDC 59630-551-07

Open in the dashboard

General payments

$599,907

7,069 payments

Research payments

$0

0 payments

Through program year 2020, $599,907 in general payments and $0 in research payments were reported against Mulpleta (Hepatology (Liver, Pancreatic, Gall Bladder)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $155,602 886
2019 General $444,305 6,183

Breakdown

Who paid General payments · program years 2019–2020
  1. Shionogi Inc $599,907 7,069 payments
Top recipients General payments · program year 2020
  1. Naim Alkhouri Gastroenterology · Westlake, OH $20,775 13% · 5 payments
  2. Robert Brown Hepatology · New York, NY $14,373 9% · 4 payments
  3. Parvez Mantry Gastroenterology · Dallas, TX $12,234 8% · 5 payments
  4. Pierre Gholam Gastroenterology · Cleveland, OH $11,713 8% · 7 payments
  5. Sammy Saab Gastroenterology · Los Angeles, CA $11,298 7% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Gastroenterology Internal Medicine $107,099 72% · 568 practitioners
  2. Hepatology Internal Medicine $28,480 19% · 10 practitioners
  3. Transplant Hepatology Internal Medicine $7,155 5% · 9 practitioners
  4. Vascular & Interventional Radiology Radiology $2,643 2% · 8 practitioners
  5. Internal Medicine $725 <1% · 23 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $48,910 31% · 87 recipients
  2. California $26,940 17% · 108 recipients
  3. New York $17,109 11% · 14 recipients
  4. Ohio $15,939 10% · 46 recipients
  5. Massachusetts $8,379 5% · 4 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

7,069 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record